Log in
NASDAQ:EGRX

Eagle Pharmaceuticals SEC Filings & 10K Form

$46.70
+1.20 (+2.64 %)
(As of 12/1/2020 12:00 AM ET)
Add
Compare
Today's Range
$45.48
Now: $46.70
$47.75
50-Day Range
$45.03
MA: $47.34
$51.34
52-Week Range
$33.80
Now: $46.70
$62.41
Volume127,204 shs
Average Volume167,710 shs
Market Capitalization$608.50 million
P/E Ratio133.43
Dividend YieldN/A
Beta0.81

SEC Filings

Eagle Pharmaceuticals (NASDAQ:EGRX) SEC Filings

DateFilerForm TypeView
11/02/2020
7:02 PM
Eagle Pharmaceuticals (Issuer)
Ng-Cashin Judith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2020
7:00 PM
Eagle Pharmaceuticals (Issuer)
Ng-Cashin Judith (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/02/2020
4:22 PM
Eagle Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2020
6:28 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2020
6:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2020
7:48 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2020
6:35 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2020
6:11 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2020
6:57 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2020
3:38 PM
ARMISTICE CAPITAL, LLC (Filed by)
Eagle Pharmaceuticals (Subject)
Form SC 13G
08/10/2020
6:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
4:23 PM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2020
3:00 PM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2020
4:16 PM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2020
6:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2020
4:29 PM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2020
6:22 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
4:09 PM
Eagle Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2020
6:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2020
6:01 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2020
6:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2020
6:11 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2020
6:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2020
6:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2020
6:17 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
6:09 AM
Eagle Pharmaceuticals (Subject)
Tarriff Scott (Filed by)
Form SC 13G/A
02/04/2020
10:53 AM
BlackRock Inc. (Filed by)
Eagle Pharmaceuticals (Subject)
Form SC 13G/A
01/27/2020
3:17 PM
Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
3:15 PM
Eagle Pharmaceuticals (Issuer)
Pernock David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
3:14 PM
Eagle Pharmaceuticals (Issuer)
Meyers Pete A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
3:13 PM
Eagle Pharmaceuticals (Issuer)
Hepner Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
6:00 AM
Eagle Pharmaceuticals (Filed by)
TYME TECHNOLOGIES, INC. (Subject)
Form SC 13G
01/16/2020
4:05 PM
Eagle Pharmaceuticals (Subject)
Hudson Executive Capital LP (Filed by)
Form SC 13D/A
01/13/2020
6:46 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
5:55 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
4:21 PM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
5:29 PM
Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
5:27 PM
Eagle Pharmaceuticals (Issuer)
Simpson Jennifer K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
5:26 PM
Eagle Pharmaceuticals (Issuer)
RATOFF STEVEN B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
5:25 PM
Eagle Pharmaceuticals (Issuer)
Pernock David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
5:24 PM
Eagle Pharmaceuticals (Issuer)
Meyers Pete A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
5:22 PM
Eagle Pharmaceuticals (Issuer)
Hepner Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
5:21 PM
Eagle Pharmaceuticals (Issuer)
Graves Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
5:20 PM
Eagle Pharmaceuticals (Issuer)
Glenning Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
5:19 PM
Eagle Pharmaceuticals (Issuer)
Edlin Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
7:02 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2019
6:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2019
5:55 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
11:15 PM
Eagle Pharmaceuticals (Filer)
Form EFFECT
12/16/2019
6:06 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
6:02 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
5:55 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
6:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2019
6:14 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2019
4:12 PM
Eagle Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2019
5:55 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
3:30 PM
Eagle Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
6:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2019
3:40 PM
Braunstein Douglas L (Reporting)
Eagle Pharmaceuticals (Issuer)
HEC Management GP LLC (Reporting)
Hudson Executive Capital LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2019
5:58 PM
Braunstein Douglas L (Reporting)
Eagle Pharmaceuticals (Issuer)
HEC Management GP LLC (Reporting)
Hudson Executive Capital LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2019
6:30 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2019
4:29 PM
Braunstein Douglas L (Reporting)
Eagle Pharmaceuticals (Issuer)
HEC Management GP LLC (Reporting)
Hudson Executive Capital LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
5:24 PM
Braunstein Douglas L (Reporting)
Eagle Pharmaceuticals (Issuer)
HEC Management GP LLC (Reporting)
Hudson Executive Capital LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2019
7:46 AM
Eagle Pharmaceuticals (Filer)
Form 8-K/A
10/10/2019
7:02 AM
Eagle Pharmaceuticals (Issuer)
Simpson Jennifer K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2019
3:13 PM
Braunstein Douglas L (Reporting)
Eagle Pharmaceuticals (Issuer)
HEC Management GP LLC (Reporting)
Hudson Executive Capital LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2019
6:30 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2019
6:30 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2019
3:13 PM
Braunstein Douglas L (Reporting)
Eagle Pharmaceuticals (Issuer)
HEC Management GP LLC (Reporting)
Hudson Executive Capital LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2019
3:43 PM
Braunstein Douglas L (Reporting)
Eagle Pharmaceuticals (Issuer)
HEC Management GP LLC (Reporting)
Hudson Executive Capital LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
3:45 PM
Eagle Pharmaceuticals (Issuer)
Simpson Jennifer K. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2019
3:30 PM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
3:50 PM
Eagle Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
6:01 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
6:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2019
3:17 PM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2019
6:15 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2019
6:06 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2019
5:29 AM
Eagle Pharmaceuticals (Subject)
Hudson Executive Capital LP (Filed by)
Form SC 13D/A
05/13/2019
4:52 PM
Braunstein Douglas L (Reporting)
Eagle Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
6:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2019
4:06 PM
Eagle Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
6:05 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2019
6:01 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
6:18 AM
Eagle Pharmaceuticals (Filer)
Form DEFA14A
04/30/2019
6:16 AM
Eagle Pharmaceuticals (Filer)
Form DEF 14A
04/15/2019
6:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
3:42 PM
Eagle Pharmaceuticals (Issuer)
RATOFF STEVEN B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
3:41 PM
Eagle Pharmaceuticals (Issuer)
FLAUM SANDER A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
3:31 PM
Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
4:12 PM
Eagle Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2019
6:17 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2019
6:00 AM
Eagle Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
4:00 PM
Eagle Pharmaceuticals (Subject)
Tarriff Scott (Filed by)
Form SC 13G/A
02/14/2019
3:55 PM
Eagle Pharmaceuticals (Subject)
Park West Asset Management LLC (Filed by)
Form SC 13G/A
02/14/2019
10:52 AM
Eagle Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/12/2019
8:18 AM
Eagle Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
02/04/2019
7:04 PM
Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2019
12:37 PM
Eagle Pharmaceuticals (Subject)
VICTORY CAPITAL MANAGEMENT INC (Filed by)
Form SC 13G/A
01/28/2019
1:50 PM
BlackRock Inc. (Filed by)
Eagle Pharmaceuticals (Subject)
Form SC 13G/A
This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.